Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 6, 2011, Pages 682-690

  Tomayko, Emily J ^a   Chung, Hae R ^a   Wilund, Kenneth R ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Atherosclerosis; Bone; Exercise; Soy; Uremia

Indexed keywords

CHOLESTEROL; SOYBEAN PROTEIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; BONE DENSITY; BONE STRUCTURE; CALCIFICATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDURANCE TRAINING; FEMALE; FOOD COMPOSITION; KIDNEY FAILURE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEDENTARY LIFESTYLE; THERAPY EFFECT; TREADMILL EXERCISE; UREA BLOOD LEVEL; UREMIA;

ANIMALS; ATHEROSCLEROSIS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CALCIUM; FEMALE; MICE; MICE, KNOCKOUT; PHYSICAL CONDITIONING, ANIMAL; SOYBEAN PROTEINS; UREMIA;

EID: 83055194713     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-011-0278-4     Document Type: Article

References (48)

1. TM Doherty LA Fitzpatrick D Inoue JH Qiao MC Fishbein RC Detrano PK Shah TB Rajavashisth 2004 Molecular, endocrine, and genetic mechanisms of arterial calcification Endocr Rev 25 629 672 15294885 10.1210/er.2003-0015 1:CAS:528:DC%2BD2cXns1Ght7w%3D (Pubitemid 39096073)
2. S Moe T Drueke J Cunningham W Goodman K Martin K Olgaard S Ott S Sprague N Lameire G Eknoyan 2006 Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 69 1945 1953 16641930 10.1038/sj.ki.5000414 1:STN:280:DC%2BD283ptl2nug%3D%3D (Pubitemid 43924257)
3. CO Stehman-Breen DJ Sherrard AM Alem DL Gillen SR Heckbert CS Wong A Ball NS Weiss 2000 Risk factors for hip fracture among patients with end-stage renal disease Kidney Int 58 2200 2205 11044242 10.1111/j.1523-1755.2000.00394.x 1:STN:280:DC%2BD3M%2FivFSqsQ%3D%3D
4. SM Moe T Drueke 2008 Improving global outcomes in mineral and bone disorders Clin J Am Soc Nephrol 3 (suppl 3) S127 S130 10.2215/CJN.04331206
5. WG Goodman G London K Amann GA Block C Giachelli KA Hruska M Ketteler A Levin Z Massy DA McCarron P Raggi CM Shanahan N Yorioka 2004 Vascular calcification in chronic kidney disease Am J Kidney Dis 43 572 579 14981617 10.1053/j.ajkd.2003.12.005 (Pubitemid 38298218)
6. NM Hujairi B Afzali DJ Goldsmith 2004 Cardiac calcification in renal patients: what we do and don't know Am J Kidney Dis 43 234 243 14750088 10.1053/j.ajkd.2003.10.014 1:CAS:528:DC%2BD2cXhsl2msL0%3D (Pubitemid 38146321)
7. SM Moe NX Chen 2004 Pathophysiology of vascular calcification in chronic kidney disease Circ Res 95 560 567 15375022 10.1161/01.RES.0000141775.67189.98 1:CAS:528:DC%2BD2cXntlyjurw%3D (Pubitemid 39274370)
8. LL Demer Y Tintut 2003 Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture Arterioscler Thromb Vasc Biol 23 1739 1743 12958041 10.1161/01.ATV.0000093547. 63630.0F 1:CAS:528:DC%2BD3sXnslWit7k%3D (Pubitemid 37254856)
9. M Abedin Y Tintut LL Demer 2004 Vascular calcification: mechanisms and clinical ramifications Arterioscler Thromb Vasc Biol 24 1161 1170 15155384 10.1161/01.ATV.0000133194.94939.42 1:CAS:528:DC%2BD2cXlt1Wlu7w%3D (Pubitemid 38880003)
10. MG Jakoby IV CF Semenkovich 2000 The role of osteoprogenitors in vascular calcification Curr Opin Nephrol Hypertens 9 11 15 10.1097/00041552-200001000- 00003 (Pubitemid 30041741)
11. BD Parker LJ Schurgers VM Brandenburg RH Christenson C Vermeer M Ketteler MG Shlipak MA Whooley JH Ix 2010 The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study Ann Intern Med 152 640 648 20479029
12. B Pecovnik Balon M Knehtl S Bevc E Jakopin M Gorenjak 2010 Fetuin-A as a risk factor for mortality in hemodialysis patients Wien Klin Wochenschr 122 (suppl 2) 63 67 10.1007/s00508-010-1348-7
13. MR Adams DL Golden MS Anthony TC Register JK Williams 2002 The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins J Nutr 132 43 49 11773506 1:CAS:528:DC%2BD38Xjt1entg%3D%3D (Pubitemid 34042453)
14. MC Erlandsson U Islander S Moverare C Ohlsson H Carlsten 2005 Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice APMIS 113 317 323 16011657 10.1111/j.1600-0463.2005.apm- 113502.x 1:CAS:528:DC%2BD2MXmsFKqt74%3D (Pubitemid 40904300)
15. J Mathey J Mardon N Fokialakis C Puel S Kati-Coulibaly S Mitakou C Bennetau-Pelissero V Lamothe MJ Davicco P Lebecque MN Horcajada V Coxam 2007 Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol Osteoporos Int 18 671 679 17333448 10.1007/s00198-007-0351-y 1:CAS:528:DC%2BD2sXjs1ektrY%3D (Pubitemid 46525554)
16. K Taku K Umegaki Y Sato Y Taki K Endoh S Watanabe 2007 Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials Am J Clin Nutr 85 1148 1156 17413118 1:CAS:528:DC%2BD2sXks1Ogsb4%3D (Pubitemid 46557934)
17. JW Anderson BM Johnstone ME Cook-Newell 1995 Meta-analysis of the effects of soy protein intake on serum lipids N Engl J Med 333 276 282 7596371 10.1056/NEJM199508033330502 1:CAS:528:DyaK2MXntlKht74%3D
18. 41Ca J Clin Endocrinol Metab 92 577 582 17148567 10.1210/jc.2006-0369 1:CAS:528:DC%2BD2sXitVaksbk%3D
19. FS Dalais PR Ebeling D Kotsopoulos BP McGrath HJ Teede 2003 The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women Clin Endocrinol (Oxf) 58 704 709 10.1046/j.1365-2265. 2003.01771.x 1:CAS:528:DC%2BD3sXlt12htbk%3D (Pubitemid 36702729)
20. CB Tempfer EK Bentz S Leodolter G Tscherne F Reuss HS Cross JC Huber 2007 Phytoestrogens in clinical practice: a review of the literature Fertil Steril 87 1243 1249 17490659 10.1016/j.fertnstert.2007.01.120 1:CAS:528: DC%2BD2sXnvFamsLc%3D (Pubitemid 46829161)
21. FM Sacks A Lichtenstein L Van Horn W Harris P Kris-Etherton M Winston 2006 Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee Circulation 113 1034 1044 16418439 10.1161/CIRCULATIONAHA.106.171052 1:CAS:528:DC%2BD28XhtlGktLY%3D (Pubitemid 43879479)
22. KR Wilund 2007 Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease? Clin Sci (Lond) 112 543 555 10.1042/CS20060368 1:CAS:528:DC%2BD2sXkslCktrw%3D (Pubitemid 46849545)
23. WY Qunibi 2005 Reducing the burden of cardiovascular calcification in patients with chronic kidney disease J Am Soc Nephrol 16 (suppl 2) S95 S102 10.1681/ASN.2005060666 (Pubitemid 46173246)
24. J Wu X Wang H Chiba M Higuchi T Nakatani O Ezaki H Cui K Yamada Y Ishimi 2004 Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice Metabolism 53 942 948 15254891 10.1016/j.metabol.2004.01.019 1:CAS:528:DC%2BD2cXlt1eltbg%3D (Pubitemid 38829472)
25. HY Oh S Lim JM Lee DY Kim ES Ann S Yoon 2007 A combination of soy isoflavone supplementation and exercise improves lipid profiles and protects antioxidant defense-systems against exercise-induced oxidative stress in ovariectomized rats Biofactors 29 175 185 18057549 10.1002/biof.5520290402 1:CAS:528:DC%2BD2sXhtlCls7%2FF
26. S Bro JF Bentzon E Falk CB Andersen K Olgaard LB Nielsen 2003 Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice J Am Soc Nephrol 14 2466 2474 14514724 10.1097/01.ASN.0000088024.72216.2E 1:CAS:528:DC%2BD3sXnt1aht7g%3D (Pubitemid 37169332)
27. IG Nikolov N Joki T Nguyen-Khoa O Ivanovski O Phan B Lacour TB Drueke ZA Massy LM Dos Reis V Jorgetti MH Lafage-Proust 2010 Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure Bone (NY) 47 156 163 1:CAS:528:DC%2BC3cXntVCrtLk%3D
28. J Niebauer AJ Maxwell PS Lin D Wang PS Tsao JP Cooke 2003 NOS inhibition accelerates atherogenesis: reversal by exercise Am J Physiol Heart Circ Physiol 285 H535 H540 12598230 1:CAS:528:DC%2BD3sXmsVagsro%3D
29. V Schefer MI Talan 1996 Oxygen consumption in adult and aged C57BL/6J mice during acute treadmill exercise of different intensity Exp Gerontol 31 387 392 9415121 10.1016/0531-5565(95)02032-2 1:STN:280:DyaK1c%2Fns1yhuw%3D%3D (Pubitemid 26170725)
30. JA Woods MA Ceddia MD Zack TW Lowder Q Lu 2003 Exercise training increases the naive to memory T cell ratio in old mice Brain Behav Immun 17 384 392 12946660 10.1016/S0889-1591(03)00030-8 1:STN:280:DC%2BD3svgslOrsA%3D%3D (Pubitemid 36999845)
31. B MacNeil L Hoffman-Goetz 1993 Effect of exercise on natural cytotoxicity and pulmonary tumor metastases in mice Med Sci Sports Exerc 25 922 928 8371653 1:STN:280:DyaK3szot1ejsQ%3D%3D (Pubitemid 23228352)
32. A Daugherty SC Whitman 2003 Quantification of atherosclerosis in mice Methods Mol Biol 209 293 309 12357958
33. P Liuba P Karnani E Pesonen I Paakkari A Forslid L Johansson K Persson T Wadstrom R Laurini 2000 Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice Circulation 102 1039 1044 10961970 1:CAS:528:DC%2BD3cXmslSksbk%3D (Pubitemid 30656012)
34. P Liuba E Pesonen I Paakkari S Batra L Andersen A Forslid S Yla-Herttuala K Persson T Wadstrom X Wang R Laurini 2003 Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice J Vasc Res 40 115 122 12808347 10.1159/000070708 1:CAS:528:DC%2BD3sXks12qsbs%3D (Pubitemid 36735221)
35. CM Weaver E Janle B Martin S Browne H Guiden P Lachcik WH Lee 2009 Dairy versus calcium carbonate in promoting peak bone mass and bone maintenance during subsequent calcium deficiency J Bone Miner Res 24 1411 1419 19309298 10.1359/jbmr.090303 1:CAS:528:DC%2BD1MXhtFaitrjO
36. IR Rowland H Wiseman TA Sanders H Adlercreutz EA Bowey 2000 Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora Nutr Cancer 36 27 32 10798213 10.1207/S15327914NC3601-5 1:CAS:528:DC%2BD3cXjtF2msrY%3D (Pubitemid 30317832)
37. KD Setchell C Clerici ED Lephart SJ Cole C Heenan D Castellani BE Wolfe L Nechemias-Zimmer NM Brown TD Lund RJ Handa JE Heubi 2005 S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora Am J Clin Nutr 81 1072 1079 15883431 1:CAS:528:DC%2BD2MXktlylurk%3D (Pubitemid 41724948)
38. PD Chilibeck SM Cornish 2008 Effect of estrogenic compounds (estrogen or phytoestrogens) combined with exercise on bone and muscle mass in older individuals Appl Physiol Nutr Metab 33 200 212 18347673 10.1139/H07-140 1:CAS:528:DC%2BD1cXjtlagtLg%3D
39. P Kontessis S Jones R Dodds R Trevisan R Nosadini P Fioretto M Borsato D Sacerdoti G Viberti 1990 Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins Kidney Int 38 136 144 2166857 10.1038/ki.1990.178 1:CAS:528:DyaK3cXkvFKntLc%3D (Pubitemid 20209443)
40. K Siefker RA DiSilvestro 2006 Safety and antioxidant effects of a modest soy protein intervention in hemodialysis patients J Med Food 9 368 372 17004900 10.1089/jmf.2006.9.368 1:CAS:528:DC%2BD28XhtVSnsLzM (Pubitemid 44850721)
41. SR Teixeira KA Tappenden L Carson R Jones M Prabhudesai WP Marshall JW Erdman Jr 2004 Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy J Nutr 134 1874 1880 15284369 1:CAS:528: DC%2BD2cXmsFChsLk%3D (Pubitemid 39031310)
42. MT Velasquez SJ Bhathena 2001 Dietary phytoestrogens: a possible role in renal disease protection Am J Kidney Dis 37 1056 1068 11325691 10.1016/S0272-6386(05)80025-3 1:CAS:528:DC%2BD3MXjvFKht78%3D (Pubitemid 32436581)
43. V Menon JD Kopple X Wang GJ Beck AJ Collins JW Kusek T Greene AS Levey MJ Sarnak 2009 Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study Am J Kidney Dis 53 208 217 18950911 10.1053/j.ajkd.2008.08.009 1:CAS:528:DC%2BD1MXivVWgsb0%3D
44. SF Leavey RL Strawderman CA Jones FK Port PJ Held 1998 Simple nutritional indicators as independent predictors of mortality in hemodialysis patients Am J Kidney Dis 31 997 1006 9631845 10.1053/ajkd.1998.v31.pm9631845 1:STN:280:DyaK1c3ptlKjtA%3D%3D (Pubitemid 28265197)
45. TA Ikizler RM Hakim 1996 Nutrition in end-stage renal disease Kidney Int 50 343 357 8840260 10.1038/ki.1996.323 1:STN:280:DyaK28vjslKisQ%3D%3D (Pubitemid 26274359)
46. UG Bronas 2009 Exercise training and reduction of cardiovascular disease risk factors in patients with chronic kidney disease Adv Chronic Kidney Dis 16 449 458 19801135 10.1053/j.ackd.2009.07.005
47. O Phan O Ivanovski T Nguyen-Khoa N Mothu J Angulo R Westenfeld M Ketteler N Meert J Maizel IG Nikolov R Vanholder B Lacour TB Drueke ZA Massy 2005 Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice Circulation 112 2875 2882 16267260 10.1161/CIRCULATIONAHA105. 541854 1:CAS:528:DC%2BD2MXhtFCru7bL (Pubitemid 41641683)
48. O Ivanovski D Szumilak T Nguyen-Khoa N Ruellan O Phan B Lacour B Descamps-Latscha TB Drueke ZA Massy 2005 The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice Kidney Int 67 2288 2294 15882270 10.1111/j.1523-1755.2005.00332.x 1:CAS:528:DC%2BD2MXlsFyjtbk%3D (Pubitemid 41623388)